Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints

Contraception(2020)10.1016/j.contraception.2020.08.008Source: DataRank Database

Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints is a research paper published in Contraception (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.23)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Zipatly Mendoza,Stacey Hurst ORCID,Lauren B. Zapata ORCID,Rachel Powell ORCID,Yari Vale

Live enrichment

PubMed:32858052 PMC:PMC7606820 OpenAlex:https://openalex.org/W3081421624

Allergan Foundation

Grant: Medicines360

Intramural CDC HHS

Grant: CC999999

American College of Obstetricians and Gynecologists

Bayer Corporation

Centers for Disease Control and Prevention

Centers for Disease Control and Prevention Foundation

School of Dentistry, University of California, San Francisco

Pfizer Foundation

Bill and Melinda Gates Foundation

William and Flora Hewlett Foundation

National CMV Foundation

FWCI

1.23

Citation Percentile

0.8%

Citation Trend

2020

2021

2023

2024

2025

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7606820

publisherhttps://api.elsevier.com/content/article/PII:S0010782420303310?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0010782420303310?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.contraception.2020.08.008

Fields of Study

Global Maternal and Child HealthCOVID-19 Impact on ReproductionReproductive Health and ContraceptionContraceptionFemaleHealth Services AccessibilityHumansLong-Acting Reversible ContraceptionPatient Reported Outcome MeasuresPregnancyZika VirusZika Virus Infection

MeSH Terms

Patient Reported Outcome MeasuresZika Virus InfectionZika VirusLong-Acting Reversible ContraceptionContraceptionFemaleHealth Services AccessibilityHumansPregnancy

Keywords

MedicineLong-acting reversible contraceptionUnintended pregnancyEmergency contraceptionZika virusFamily planningReproductive healthFamily medicinePillGynecologyPopulationNursingEnvironmental healthEmergency ResponseLong-acting Reversible Contraception (Larc)Reproductive AutonomyZikaLarc Removal

Sustainable Development Goals

SDG 0: Good health and well-being